Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has priced an offering of $1.5 billion aggregate principal amount of the following notes:
- $750 million aggregate principal amount of its 3.200% senior notes due 2027, at an issue price of 99.263% of their principal amount and
- $750 million aggregate principal amount of its 4.100% senior notes due 2047, at an issue price of 98.825% of their principal amount.
The issuance of the notes is expected to close on August 14, 2017, subject to customary closing conditions. The notes will pay interest on a semi-annual basis.
Thermo Fisher intends to use all of the net proceeds of the offering to fund a portion of the consideration payable for its acquisition of Patheon N.V. (NYSE: PTHN), including the repayment of indebtedness of Patheon N.V. to be assumed by Thermo Fisher. As previously announced, Thermo Fisher now expects to complete the transaction around the end of the third quarter of 2017, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals and completion of Thermo Fisher's tender offer to acquire all of the issued and outstanding shares of Patheon N.V.